BamSEC and AlphaSense Join Forces
Learn More

Pulmonx Corporation

NASDAQ: LUNG    
Share price (3/20/25): $7.70    
Market cap (3/20/25): $306 million

Material Contracts Filter

EX-10.34
from 10-K 2 pages Material contract
12/34/56
EX-10.2
from 8-K 9 pages Third Amendment to Consent to Sublease Agreement
12/34/56
EX-10.1
from 8-K 26 pages Third Amendment to Office Lease
12/34/56
EX-10.1
from 8-K 5 pages March 19, 2024 Position You Will Start in a Full-Time, Exempt Position as Chief Financial Officer Working Out of the Company’s Office in Redwood City, California. You Will Report to Me, Steve Williamson, President and Chief Executive Officer (CEO). Compensation
12/34/56
EX-10.30
from 10-K 3 pages Pulmonx Corporation Amended and Restated Non-Employee Director Compensation Policy Approved by the Compensation Committee of the Board of Directors December 13, 2023
12/34/56
EX-10.2
from 8-K 5 pages Dear Steve: On Behalf of Pulmonx (The “Company” or “Pulmonx”) I Am Pleased to Offer You Employment With the Company Beginning on March 15, 2024 or a Date That Is Mutually Agreed Upon (The “Start Date”) on the Terms Described Below. Position You Will Start in a Full-Time, Exempt Position as President and Chief Executive Officer. You Will Report to the Pulmonx Board of Directors (The “Board”). You Will Also Be Appointed to the Board. Compensation
12/34/56
EX-10.1
from 8-K 1 page February 20, 2024 via Email/Docusign Glendon E. French President and Chief Executive Officer Dear Glen
12/34/56
EX-10.1
from 10-Q 6 pages Pulmonx Corporation Consulting Agreement Effective Date: November 1, 2023
12/34/56
EX-10.2
from 10-Q 5 pages Second Amendment to Sublease
12/34/56
EX-10.1
from 10-Q 3 pages Pulmonx Corporation Amended and Restated Non-Employee Director Compensation Policy Approved by the Compensation Committee of the Board of Directors May 16, 2023
12/34/56
EX-10.3
from 10-Q 3 pages Pulmonx Corporation Amended and Restated Non-Employee Director Compensation Policy Approved by the Board of Directors March 23, 2021
12/34/56
EX-10.2
from 10-Q 57 pages Material contract
12/34/56
EX-10.13
from 10-K 5 pages Dear David: On Behalf of Pulmonx (The “Company”), I Am Pleased to Offer You Employment With the Company Beginning as Soon as Possible but No Later Than October 15, 2020 (The “Start Date”) on the Terms Described Below. Position You Will Start in a Full-Time, Exempt Position as General Counsel Working Out of the Company’s Office in Redwood City, California. You Will Report to Me. of Course, the Company May Change Your Position, Duties, and Work Location From Time to Time in Its Discretion. Compensation You Will Be Paid an Annual Salary of $400,000. Your Salary Will Be Payable in Two Equal Payments Per Month Pursuant to Pulmonx’s Regular Payroll Policy (Subject to Normal Required Withholding). Your Base Salary Will Be Reviewed Annually as Part of the Company’s Normal Salary Review Process. Annual Bonus
12/34/56
EX-10.28
from S-1/A 2 pages Pulmonx Corporation Non-Employee Director Compensation Policy Approved by the Board of Directors September 15, 2020
12/34/56
EX-10.27
from S-1/A 19 pages Pulmonx Corporation Severance and Change in Control Plan
12/34/56
EX-10.22
from S-1/A 19 pages First Amendment to Sublease
12/34/56
EX-10.9
from S-1/A 15 pages Pulmonx Corporation Indemnification Agreement
12/34/56
EX-10.8
from S-1/A 13 pages Pulmonx Corporation 2020 Employee Stock Purchase Plan Adopted by the Board of Directors: September 15, 2020 Approved by the Stockholders: September 16, 2020 Ipo Date: , 2020
12/34/56
EX-10.7
from S-1/A 5 pages Pulmonx Corporation Rsu Award Grant Notice
12/34/56
EX-10.6
from S-1/A 7 pages Pulmonx Corporation Stock Option Grant Notice
12/34/56